Nanoviricides, Inc. (NNVC): Operating Income
-$9.59M
Year ended 2025-06-30
-$8.18M
Trailing 12 months to 2026-03-31
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-06-30 | -$9.59M | n/m | 2025-09-29, From 2024-07-01 |
| 2024-06-30 | -$8.52M | n/m | 2025-09-29, From 2023-07-01 |
| 2023-06-30 | -$8.94M | n/m | 2024-09-27, From 2022-07-01 |
| 2022-06-30 | -$8.11M | n/m | 2023-10-13, From 2021-07-01 |
| 2021-06-30 | -$8.74M | n/m | 2022-10-13, From 2020-07-01 |
| 2020-06-30 | -$8.00M | n/m | 2021-10-12, From 2019-07-01 |
| 2019-06-30 | -$8.66M | n/m | 2021-10-12, From 2018-07-01 |
| 2018-06-30 | -$9.33M | n/m | 2020-10-13, From 2017-07-01 |
| 2017-06-30 | -$9.60M | n/m | 2019-08-23, From 2016-07-01 |
| 2016-06-30 | -$8.86M | n/m | 2018-10-12, From 2015-07-01 |
| 2015-06-30 | -$7.06M | n/m | 2017-09-28, From 2014-07-01 |
| 2014-06-30 | -$8.67M | n/m | 2016-09-16, From 2013-07-01 |
| 2013-06-30 | -$6.59M | n/m | 2015-09-14, From 2012-07-01 |
| 2012-06-30 | -$6.08M | n/m | 2015-02-23, From 2011-07-01 |
| 2011-06-30 | -$6.43M | n/a | 2013-10-08, From 2010-06-30 |
| 2010-06-30 | -$4.94M | n/a | 2012-10-26, From 2009-07-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Nanoviricides, Inc. (NNVC) | 2025-06-30 | -$9.59M | n/m |
| Abbott Laboratories (ABT) | 2025-12-31 | $8.05B | +18.0% |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | -$4.39M | n/m |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $24.74M | +23.1% |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | -$5.29M | n/m |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | -$18.21M | n/m |
| Procyon Corp (PCYN) | 2024-06-30 | -$231.7K | n/m |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | -$2.54M | n/m |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $2.16B | n/m |
Compare NNVC, ABT, TXMD, NATR side by side · Screen every company in Pharmaceutical Preparations ↗